What is the address of KADALE MEDICAL?

The registered office of KADALE MEDICAL is located at Avenue du Cheret 23, 4053 Chaudfontaine.

Is KADALE MEDICAL still active?

Yes. According to the CBE (31 October 2026) KADALE MEDICAL is active, legal situation “Normale toestand”, started on 20 October 2020.

Is KADALE MEDICAL registered on Peppol?

Yes, KADALE MEDICAL is registered on the Peppol network with ID 0208:0756773016.

What is the enterprise number of KADALE MEDICAL?

The enterprise number of KADALE MEDICAL is BE0756773016.

When was KADALE MEDICAL founded?

KADALE MEDICAL was founded on 20 October 2020.

Who are the directors of KADALE MEDICAL?

According to the 2025 annual accounts, the directors of KADALE MEDICAL are: Jean-Vincent Bavi.

Is KADALE MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 October 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did KADALE MEDICAL make in 2025?

KADALE MEDICAL posted a profit after taxes of € 93,081 in financial year 2025.

What is the revenue of KADALE MEDICAL?

As a small company, KADALE MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 282,092.

KADALE MEDICAL (Private Limited) - Chaudfontaine

Dossier KADALE MEDICAL, printed on 1 November 2026 from databakkes.be/en/0756773016/kadale-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

KADALE MEDICAL from Chaudfontaine, company number BE0756773016, closed financial year 2025 with a result of € 93,081 after tax. For that financial year KADALE MEDICAL recorded a gross margin of € 282,092 and equity of € 551,319. Compared with financial year 2024, the result moved from € 125,956 to € 93,081. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 17, 2026.

What it is worth Growing

€ 551,319

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 93,081

▼ 26% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 329,889

▲ 36% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,000 paid out

54 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 25,648

▼ 50% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 199,520

▲ 19% vs 2024

€ 30,955 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 5,722

▼ 88% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 3,307

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 173,045 Gross margin 2022: € 173,045 First fiscal year in the series	€ 221,674 Gross margin 2023: € 221,674 ▲ 28% vs 2022 (€ 173,045) Favourable step	€ 232,003 Gross margin 2024: € 232,003 ▲ 5% vs 2023 (€ 221,674) Favourable step	€ 282,092 Gross margin 2025: € 282,092 ▲ 22% vs 2024 (€ 232,003) Favourable step	▲ 22%
Profit after taxes	€ 111,379 Profit after taxes 2022: € 111,379 First fiscal year in the series	€ 139,835 Profit after taxes 2023: € 139,835 ▲ 26% vs 2022 (€ 111,379) Favourable step	€ 125,956 Profit after taxes 2024: € 125,956 ▼ 10% vs 2023 (€ 139,835) Unfavourable step	€ 93,081 Profit after taxes 2025: € 93,081 ▼ 26% vs 2024 (€ 125,956) Unfavourable step	▼ 26%
Equity	€ 292,425 Equity 2022: € 292,425 First fiscal year in the series	€ 432,260 Equity 2023: € 432,260 ▲ 48% vs 2022 (€ 292,425) Favourable step	€ 508,216 Equity 2024: € 508,216 ▲ 18% vs 2023 (€ 432,260) Favourable step	€ 551,319 Equity 2025: € 551,319 ▲ 8% vs 2024 (€ 508,216) Favourable step	▲ 8%
Total debts	€ 271,021 Total debts 2022: € 271,021 First fiscal year in the series	€ 178,706 Total debts 2023: € 178,706 ▼ 34% vs 2022 (€ 271,021) Favourable step	€ 273,423 Total debts 2024: € 273,423 ▲ 53% vs 2023 (€ 178,706) Unfavourable step	€ 293,432 Total debts 2025: € 293,432 ▲ 7% vs 2024 (€ 273,423) Unfavourable step	▲ 7%
Cash	€ 218,912 Cash 2022: € 218,912 First fiscal year in the series	€ 239,675 Cash 2023: € 239,675 ▲ 9% vs 2022 (€ 218,912) Favourable step	€ 243,374 Cash 2024: € 243,374 ▲ 2% vs 2023 (€ 239,675) Favourable step	€ 329,889 Cash 2025: € 329,889 ▲ 36% vs 2024 (€ 243,374) Favourable step	▲ 36%
Land & buildings	€ 135,434 Land & buildings 2022: € 135,434 First fiscal year in the series	€ 131,313 Land & buildings 2023: € 131,313 ▼ 3% vs 2022 (€ 135,434) Unchanged	€ 212,175 Land & buildings 2024: € 212,175 ▲ 62% vs 2023 (€ 131,313) Unchanged	€ 200,190 Land & buildings 2025: € 200,190 ▼ 6% vs 2024 (€ 212,175) Unchanged	▼ 6%
Retained profit	€ 290,425 Retained profit 2022: € 290,425 First fiscal year in the series	€ 430,260 Retained profit 2023: € 430,260 ▲ 48% vs 2022 (€ 290,425) Favourable step	€ 506,216 Retained profit 2024: € 506,216 ▲ 18% vs 2023 (€ 430,260) Favourable step	€ 549,319 Retained profit 2025: € 549,319 ▲ 9% vs 2024 (€ 506,216) Favourable step	▲ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 50,000 Dividend 2024: € 50,000 Unchanged (€ 0) Unchanged	€ 50,000 Dividend 2025: € 50,000 Unchanged (€ 50,000) Unchanged
Bank debt	€ 179,723 Bank debt 2022: € 179,723 First fiscal year in the series	€ 161,381 Bank debt 2023: € 161,381 ▼ 10% vs 2022 (€ 179,723) Favourable step	€ 167,509 Bank debt 2024: € 167,509 ▲ 4% vs 2023 (€ 161,381) Unfavourable step	€ 199,520 Bank debt 2025: € 199,520 ▲ 19% vs 2024 (€ 167,509) Unfavourable step	▲ 19%
Balance sheet total	€ 563,446 Balance sheet total 2022: € 563,446 First fiscal year in the series	€ 610,966 Balance sheet total 2023: € 610,966 ▲ 8% vs 2022 (€ 563,446) Unchanged	€ 781,639 Balance sheet total 2024: € 781,639 ▲ 28% vs 2023 (€ 610,966) Unchanged	€ 844,751 Balance sheet total 2025: € 844,751 ▲ 8% vs 2024 (€ 781,639) Unchanged	▲ 8%

Key figures of KADALE MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to KADALE MEDICAL?

What happened at KADALE MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 17, 2026 New annual accounts for financial year 2025: profit of € 93,081 (▼ 26% vs 2024). filed late Source: NBB ↗
Oct 20, 2020 New establishment in Chaudfontaine. KBO
Oct 20, 2020 Start of the company according to the CBE. KBO

In short

From € 111,379 profit in 2022 to € 93,081 profit in 2025.

Paid € 155,768 in corporate taxes since 2022.

Best year ever: 2023, with € 139,835 profit.

Paid out € 100,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Jean-Vincent Bavi

KADALE MEDICAL

Behind KADALE MEDICAL is Jean-Vincent Bavi.

Directors

According to the 2025 annual accounts

Jean-Vincent Bavi

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue du Cheret 23

4053 Chaudfontaine

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0756.773.016
VAT number: BE 0756.773.016
Registered office: Avenue du Cheret 23, 4053 Chaudfontaine
Names & denominations: KADALE MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 October 2020
Peppol: Active · Active since 20 Mar 2026

View on CBE Public ↗ Annual accounts (NBB) ↗